dexmedetomidine kalceks 100 mcg/ml koncentrat do sporządzania roztworu do infuzji
as kalceks - dexmedetomidinum - koncentrat do sporządzania roztworu do infuzji - 100 mcg/ml
dexmedetomidine b. braun 100 mcg/ml koncentrat do sporządzania roztworu do infuzji
b. braun melsungen ag - dexmedetomidinum - koncentrat do sporządzania roztworu do infuzji - 100 mcg/ml
dilaterol 25 mcg/1 ml syrop
le vet beheer b.v. - clenbuterol hydrochloride - syrop - 25 mcg/1 ml - koń
tigecycline teva 50 mg proszek do sporządzania roztworu do infuzji
teva pharmaceuticals polska sp. z o.o. - tigecyclinum - proszek do sporządzania roztworu do infuzji - 50 mg
tigecycline tzf 50 mg proszek do sporządzania roztworu do infuzji
tarchomińskie zakłady farmaceutyczne "polfa" s.a. - tigecyclinum - proszek do sporządzania roztworu do infuzji - 50 mg
egilipid 40 mg 40 mg tabletki powlekane
egis pharmaceuticals plc - simvastatinum - tabletki powlekane - 40 mg
egilipid 10 mg 10 mg tabletki powlekane
egis pharmaceuticals plc - simvastatinum - tabletki powlekane - 10 mg
egilipid 20 mg 20 mg tabletki powlekane
egis pharmaceuticals plc - simvastatinum - tabletki powlekane - 20 mg
abiraterone accord
accord healthcare s.l.u. - octan abirateronu - nowotwory stercza - terapia endokrynologiczna - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
abiraterone orion 500 mg tabletki powlekane
orion corporation - abirateroni acetas - tabletki powlekane - 500 mg